Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
11/2003
11/13/2003US20030212067 Bone disorders; rheumatic diseases; wound healing agents
11/13/2003US20030212049 Antiarthritic agents; osteoporosis; sepsis; antiulcer agents; Crohn's disease
11/13/2003US20030209493 Using vinylidene fluoride polymer; forming lecithin powders
11/13/2003CA2483829A1 Ionic liquids
11/12/2003EP1360222A1 Organopolysiloxanes containing phosphonic groups, methods for the production and use thereof
11/12/2003EP1360168A2 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof
11/12/2003EP1360005A2 Compound suitable for use as a catalyst or for producing a catalyst system derived from a bis-phosphorinane
11/12/2003EP1360004A1 Catalysts
11/12/2003EP1246830B1 Macrocyclic chelants for metallopharmaceuticals
11/12/2003EP1216252B1 Hydroformylation using multidentate phosphite ligands
11/12/2003EP1206265B1 Src kinase inhibitor compounds
11/12/2003EP1205483B1 Method of purifying organic phosphoric ester
11/12/2003EP1200450B1 Method for the production of phosphonomethylglycine
11/12/2003EP0983282B1 Metal complex photosensitizer and photovoltaic cell
11/12/2003EP0898574B1 Fluorescent chelates as visual tissue specific imaging agents
11/12/2003EP0871454B1 Phosphorous-containing cysteine and serine protease inhibitors
11/12/2003EP0752987B1 Pyrimidinyl derivatives as interleukin inhibitors
11/12/2003EP0590112B1 Odourless acoustic and thermal insulation
11/12/2003CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
11/12/2003CN1455765A Novel retinoid derivatives and production method thereof and anti-cancer pharmaceutical composition comprising same
11/12/2003CN1454898A Method of preparing disodium methyl nitrozole phosphate
11/12/2003CN1454897A Method for producing phosphorousphenate
11/12/2003CN1127464C Polymerizable biaryls, method for the production and use thereof
11/12/2003CN1127295C Fungicidal compositions
11/11/2003US6646170 Intermediates for the synthesis of ether compounds
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646114 Especially phosphorothioate oligonucleotides, and to intermediates used in that process; solution phase synthesis having improved efficiencies and enhanced convenience and cost
11/11/2003US6646106 Polymerizing chiral diphosphine having a C2 axis of symmetry, with one or several polymerizable monomers, said chiral diphosphine consisting of a chiral body bearing two identical functional groups
11/11/2003US6646064 Reacting epoxy resin with p-containing dihydric phenol or naphthol
11/11/2003US6646032 Thermoplastic flameproof resin composition
11/11/2003US6645989 Compounds
11/11/2003US6645976 Indolizine SPLA2inhibitors
11/11/2003US6645952 Adhesive compositions for hard tissues
11/11/2003US6645950 Benzimidazole vascular damaging agents
11/11/2003US6645904 Use as phase transfer catalysts, in halogen-fluorine exchange reactions and nucleophilic substitutions; bis(2-methoxyethyl)amino-tris(pyrrolidino)phosphonium chloride for example; lower dermal toxicity
11/11/2003US6645903 Useful in polymerization reactions, coupling reactions, and other chemical reactions which are facilitated by an appropriate cation
11/11/2003US6645742 Removal of hydrophilic impurities, proteins and inorganic salts from a solution of phosphatidylserine in organic solvent by extraction with a mixture of water and a polar organic solvent
11/11/2003CA2264569C Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
11/11/2003CA2112258C Chiral phospholanes via chiral 1,4-diol cyclic sulfates
11/11/2003CA2052800C Aryl sulphide, aryl sulphoxide and aryl sulphone compounds and processes for their preparation
11/06/2003WO2003091688A2 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine n-oxides, and phosphine oxide-pyridine n-oxides, and devices made with such complexes
11/06/2003WO2003091314A1 Blocked mercaptosilane hydrolyzates as coupling agents for mineral-filled elastomer compositions
11/06/2003WO2003091304A2 Solid supports functionalised by phosphorus dendrimers, method for preparing same and uses thereof
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003091263A1 Method for producing phosphatidylethanolamine and lysophosphatidylethanolamine using non-organic solvent system
11/06/2003WO2003091262A1 Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and poymers therefrom
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003090674A2 Compounds, compositions and methods for treating or preventing viral infections and associated diseases
11/06/2003WO2003045555A3 Process for the preparation of a nickel/phosphorus ligand catalyst for olefin hydrocyanation
11/06/2003WO2003016321A3 Novel phosphite compounds and novel phosphite metal complexes
11/06/2003WO2003009855A3 Organo-phosphorous compounds for activating gamma/delta t cells
11/06/2003WO2002034204A3 Calcilytic compounds
11/06/2003US20030208089 Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof
11/06/2003US20030207919 For treating, preventing, reducing inflammation, pain, fever,gastrointestinal disorders; decreasing gastrointestinal, renal and other toxicities resulting from use of nonsteroidal antiinflammatory drugs; multiplicity of compounds
11/06/2003US20030207899 Heterocyclylaminomethyloxazo-lidinones as antibacterials
11/06/2003US20030207895 Tissue factor antagonists and methods of use thereof
11/06/2003US20030207871 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
11/06/2003US20030207824 Pyrimidine derivatives for labeled binding partners
11/06/2003US20030207797 Glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful
11/06/2003US20030207248 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET)
11/06/2003CA2483192A1 Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and poymers therefrom
11/06/2003CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003CA2481285A1 Non nucleoside reverse transcriptase inhibitors
11/06/2003CA2449740A1 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine n-oxides, and phosphine oxide-pyridine n-oxides, and devices made with such complexes
11/05/2003EP1359178A1 Process for the preparation of a liquid formulation of phosphonium phenolates
11/05/2003EP1359145A1 Process for preparation of benzylpiperidine compounds
11/05/2003EP1358198A1 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
11/05/2003EP1358194A1 Bridged biphospholes and metallocenes prepared therefrom
11/05/2003EP1358193A1 Process for purification of phosphate esters
11/05/2003EP1358154A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/05/2003EP1358009A2 Process for the carbonylation of ethylenically unsaturated compounds, bidentate diphosphine composition used in this process and processes for preparation of this bidentate diphosphine composition
11/05/2003EP1357803A2 Methods for treating phosphatide-containing mixtures
11/05/2003EP1199310B1 Process for the preparation of condensed phosphoric esters
11/05/2003EP1140113B1 Use of bisphosphonates for the prevention and treatment of infectious processes
11/05/2003EP1080089B1 Pyrazolyldioxothiochromanoyl derivatives
11/05/2003EP0885896B1 Phospholipid composition
11/05/2003CN1126755C Process for preparing N-[5-(diphenyl phosphinyl methyl)-4-(4-fluoropheyl)-6-isopropyl pyrimidine-2-group]-N-methl methane sulfamide
11/04/2003US6642410 Useful as antiproliferative agents, including, for example, anticancer agents
11/04/2003US6642373 Activators for oligonucleotide synthesis
11/04/2003US6642217 Triterpenes having human antifungal and antiyeast activity
11/04/2003US6642193 Contacting hair and skin with effective conditioning amount of compound made by reacting epoxysuccinic acid and salt of alkyl alkoxylated surfactant in aqueous solution
11/04/2003US6642192 Amphoteric surfactants based upon epoxy succinic acid in personal care applications
11/04/2003US6641741 Removal and recovery of chloride from phosphonomethyliminodiacetic acid process brine
10/2003
10/30/2003WO2003089442A1 A method of preparing phosphoric ester
10/30/2003WO2003089406A1 A process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds
10/30/2003WO2003089393A1 Liquid vegetable unsaturated alcohol and process for producing the same
10/30/2003WO2003088917A2 Regulation of tnf-alpha
10/30/2003WO2003045552A3 Polymeric phosphorus-containing compositions and their use in hydrocyanation, unsaturated nitrile isomerization and hydroformylation reactions
10/30/2003WO2003040149A3 Asymmetric catalysis based on chiral phospholanes and hydroxyl phospholanes
10/30/2003WO2003031452A3 4-haloethenylphenyl tropane:serotonin transporter imaging agents
10/30/2003WO2002066425A3 Compositions and methods for hydration of terminal alkynes
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003WO2002063030A3 Charge tags and separation of nucleic acid molecules
10/30/2003US20030204116 Process for the production of phosphonium phenolates
10/30/2003US20030204115 Suitable for use as an organic luminescent material which emits light of desired color; flat panel displays
10/30/2003US20030204109 Purified by at least partially removing contaminating sulfite values therefrom by decreasing the pH of a solution of such sulfonated organophosphorus compounds to a value of less than or equal to 4
10/30/2003US20030204041 Ionic liquids
10/30/2003US20030203955 Administering to a patient suffering from an immune cell mediated diseases a therapeutic amount of biheterocyclic compound containing sulfone group or substituted suflone
1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 554